Association of Serum Lipids with Inflammatory Bowel Disease: a Systematic Review and Meta-analysis

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2023 Sep 11

PMID 37692785

Authors

Hongxin Chen

Weiyang Li

Jingyi Hu

Feng Xu

Yizhou Lu

Lei Zhu

Hong Shen

Affiliations

Soon will be listed here.

Abstract

Background: Serum lipid levels seem to be abnormal in Inflammatory bowel disease (IBD). However, the specific manifestation of abnormal serum lipid levels in IBD are heterogeneous among studies and have not been sufficiently determined yet.

Methods: PubMed, EMBASE, and Cochrane Library databases were searched. Serum lipid levels were compared between IBD patients and Health individuals, Crohn's (CD) and ulcerative colitis (UC), active and inactive, mild and non-mild patients, respectively. Meta-analyses were performed by using a random-effect model. Weight mean difference (WMD) with 95% confidence intervals (CIs) were calculated.

Results: Overall, 53 studies were included. Compared with healthy controls, IBD patients had significantly lower TC (WMD = -0.506, 95%CI = -0.674 to -0.338, < 0.001), HDL-c (WMD = -0.122, 95%CI = -0.205 to -0.039, = 0.004), and LDL-c (WMD = -0.371, 95%CI = -0.547 to -0.194, < 0.001) levels. CD groups had a significantly lower TC (WMD = -0.349, 95%CI = -0.528 to -0.170, < 0.0001) level as compared to UC groups. Active IBD and non-mild UC groups had significantly lower TC (WMD = -0.454, 95%CI = -0.722 to -0.187, = 0.001) (WMD =0.462, 95%CI = 0.176 to 0.748, = 0.002) and LDL-c (WMD = -0.225, 95%CI = -0.445 to -0.005, = 0.045) (WMD =0.346, 95%CI = 0.084-0.609, = 0.010) levels as compared to inactive IBD and mild UC groups, respectively.

Conclusion: The overall level of serum lipids in IBD patients is lower than that of healthy individuals and is negatively associated with disease severity.

Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, identifier: CRD42022383885.

Citing Articles

Blood Lipid Levels and Their Value as Markers of Disease Activity in Severe Ulcerative Colitis.

Zhu L, Tian L, Li S, Huo L Int J Gen Med. 2025; 18:671-680.

PMID: 39959458 PMC: 11829746. DOI: 10.2147/IJGM.S481323.

Underneath the Gut-Brain Axis in IBD-Evidence of the Non-Obvious.

Boldyreva L, Evtushenko A, Lvova M, Morozova K, Kiseleva E Int J Mol Sci. 2024; 25(22).

PMID: 39596193 PMC: 11594934. DOI: 10.3390/ijms252212125.

JAK inhibitors: an evidence-based choice of the most appropriate molecule.

Antonioli L, Armuzzi A, Fantini M, Fornai M Front Pharmacol. 2024; 15:1494901.

PMID: 39559737 PMC: 11570808. DOI: 10.3389/fphar.2024.1494901.

Applications of the Cholesterol Metabolite, 4β-Hydroxycholesterol, as a Sensitive Endogenous Biomarker for Hepatic CYP3A Activity Evaluated within a PBPK Framework.

Karkhanis A, Harwood M, Stader F, Bois F, Neuhoff S Pharmaceutics. 2024; 16(10).

PMID: 39458613 PMC: 11510160. DOI: 10.3390/pharmaceutics16101284.

Management of a Patient with Cardiovascular Disease Should Include Assessment of Primary and Secondary Immunodeficiencies: Part 2-Secondary Immunodeficiencies.

Napiorkowska-Baran K, Doligalska A, Drozd M, Czarnowska M, Laszczych D, Dolina M Healthcare (Basel). 2024; 12(19).

PMID: 39408157 PMC: 11477378. DOI: 10.3390/healthcare12191977.

References

Pallotti F, Bergamini C, Lamperti C, Fato R . The Roles of Coenzyme Q in Disease: Direct and Indirect Involvement in Cellular Functions. Int J Mol Sci. 2022; 23(1). PMC: 8745647. DOI: 10.3390/ijms23010128. View

Sadat Masjedi M, Pour P, Shokoohinia Y, Asgary S . Effects of Flaxseed on Blood Lipids in Healthy and Dyslipidemic Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr Probl Cardiol. 2021; 47(7):100931. DOI: 10.1016/j.cpcardiol.2021.100931. View

Hrabovsky V, Zadak Z, Blaha V, Hyspler R, Karlik T, Martinek A . Cholesterol metabolism in active Crohn's disease. Wien Klin Wochenschr. 2009; 121(7-8):270-5. DOI: 10.1007/s00508-009-1150-6. View

Scarpa M, Romanato G, Manzato E, Ruffolo C, Marin R, Basato S . Restorative proctocolectomy for ulcerative colitis: impact on lipid metabolism and adipose tissue and serum fatty acids. J Gastrointest Surg. 2007; 12(2):279-87. DOI: 10.1007/s11605-007-0380-z. View

Fan F, Galvin A, Fang L, White D, Moore X, Sparrow M . Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease. J Inflamm (Lond). 2014; 11(1):29. PMC: 4203921. DOI: 10.1186/s12950-014-0029-0. View

Aarestrup J, Jess T, Kobylecki C, Nordestgaard B, Allin K . Cardiovascular Risk Profile Among Patients With Inflammatory Bowel Disease: A Population-based Study of More Than 100 000 Individuals. J Crohns Colitis. 2018; 13(3):319-323. DOI: 10.1093/ecco-jcc/jjy164. View

Szczeklik K, Mach T, Cibor D, Owczarek D, Sapa J, Papiez M . Correlation of Paraoxonase-1 with the Severity of Crohn's Disease. Molecules. 2018; 23(10). PMC: 6222603. DOI: 10.3390/molecules23102603. View

Johansson C, Rossner S, Walldius G, Kollberg B . Dyslipoproteinaemia after ileal resection in Crohn's disease. Digestion. 1979; 19(2):77-85. DOI: 10.1159/000198327. View

Netea M, Demacker P, Kullberg B, Boerman O, Verschueren I, Stalenhoef A . Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest. 1996; 97(6):1366-72. PMC: 507194. DOI: 10.1172/JCI118556. View

10.

Lu L, Hu C, Zhao Y, He L, Zhou J, Li H . Shotgun Lipidomics Revealed Altered Profiles of Serum Lipids in Systemic Lupus Erythematosus Closely Associated with Disease Activity. Biomolecules. 2018; 8(4). PMC: 6315961. DOI: 10.3390/biom8040105. View

11.

Artl A, Marsche G, Pussinen P, Knipping G, Sattler W, Malle E . Impaired capacity of acute-phase high density lipoprotein particles to deliver cholesteryl ester to the human HUH-7 hepatoma cell line. Int J Biochem Cell Biol. 2002; 34(4):370-81. DOI: 10.1016/s1357-2725(01)00132-7. View

12.

Schulte D, Paulsen K, Turk K, Brandt B, Freitag-Wolf S, Hagen I . Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases. Nutr Metab Cardiovasc Dis. 2018; 28(11):1100-1105. DOI: 10.1016/j.numecd.2018.06.022. View

13.

Borba E, Carvalho J, Bonfa E . Mechanisms of dyslipoproteinemias in systemic lupus erythematosus. Clin Dev Immunol. 2006; 13(2-4):203-8. PMC: 2270754. DOI: 10.1080/17402520600876945. View

14.

Castro Aguilar-Tablada T, Navarro-Alarcon M, Quesada Granados J, Samaniego Sanchez C, Rufian-Henares J, Nogueras-Lopez F . Ulcerative Colitis and Crohn's Disease Are Associated with Decreased Serum Selenium Concentrations and Increased Cardiovascular Risk. Nutrients. 2016; 8(12). PMC: 5188435. DOI: 10.3390/nu8120780. View

15.

Coelewij L, Waddington K, Robinson G, Chocano E, McDonnell T, Farinha F . Serum Metabolomic Signatures Can Predict Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus. Arterioscler Thromb Vasc Biol. 2021; 41(4):1446-1458. PMC: 7610443. DOI: 10.1161/ATVBAHA.120.315321. View

16.

Kisilevsky R, Manley P . Acute-phase serum amyloid A: perspectives on its physiological and pathological roles. Amyloid. 2012; 19(1):5-14. DOI: 10.3109/13506129.2011.654294. View

17.

Hernandez-Camba A, Carrillo-Palau M, Ramos L, de Armas-Rillo L, Vela M, Arranz L . Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease. Clin Transl Gastroenterol. 2022; 13(6):e00500. PMC: 9236603. DOI: 10.14309/ctg.0000000000000500. View

18.

Trzeciak-Jedrzejczyk A, Makosiej R, Kolejwa M, Glowacka E, Czkwianianc E . The role of adhesion molecules in inflammatory bowel disease in children. Assessment of the possible risk of cardiovascular complications. Prz Gastroenterol. 2017; 12(3):181-185. PMC: 5672715. DOI: 10.5114/pg.2017.70480. View

19.

Feng Q, Wei W, Chaugai S, Leon B, Mosley J, Leon D . Association Between Low-Density Lipoprotein Cholesterol Levels and Risk for Sepsis Among Patients Admitted to the Hospital With Infection. JAMA Netw Open. 2019; 2(1):e187223. PMC: 6447031. DOI: 10.1001/jamanetworkopen.2018.7223. View

20.

Wada Y, Hisamatsu T, Naganuma M, Matsuoka K, Okamoto S, Inoue N . Risk factors for decreased bone mineral density in inflammatory bowel disease: A cross-sectional study. Clin Nutr. 2015; 34(6):1202-9. DOI: 10.1016/j.clnu.2015.01.003. View